The results of 5-year atorvastatin therapy at the doses of 20–40 mg daily in metabolically compromised patients at very high risk - KIVIRID

The results of 5-year atorvastatin therapy at the doses of 20–40 mg daily in metabolically compromised patients at very high risk

Authors: O Korolyuk

Published: 2020-11-26

DOI: 10.1093/ehjci/ehaa946.3342

Source: Full article

Abstract

Abstract